comparemela.com

Latest Breaking News On - Zynerba pharma - Page 1 : comparemela.com

Epilepsy Market Registers 14.5% CAGR with Impressive Growth Opportunities During the Study Period [2017-2030], Ascertains DelveInsight

Epilepsy Market Registers 14.5% CAGR with Impressive Growth Opportunities During the Study Period [2017-2030], Ascertains DelveInsight
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Germany
Italy
Japan
United-states
United-kingdom
France
Spain
Shruti-thakur
Dainippon-sumitomo-pharma
Neurocrine-biosciences
Prnewswire-delveinsight
Zynerba-pharma-zygel

Epilepsy - Worldwide Market and Epidemiology Insights & Forecasts to 2030

Epilepsy - Worldwide Market and Epidemiology Insights & Forecasts to 2030 January 22, 2021 04:08 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com s offering. This report delivers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Epilepsy market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Epilepsy market size from 2017 to 2030. The report also covers current Epilepsy treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Germany
Japan
United-states
United-kingdom
Italy
Dublin
Ireland
France
Spain
Fintepla-zogenix
Zynerba-pharma
Zygel-zynerba

vimarsana © 2020. All Rights Reserved.